Drug Designing, Biomarkers & Proteomics
Drug designing involves the use of 3D information about biomolecules obtained from analytical techniques which is more traceable when there is a high-resolution structure of a target protein bound to a potent ligand. Molecular mechanics or molecular dynamics is most often used to estimate the strength of the intermolecular interactions between the molecule and its biological target. Computational methods have geared up in the discovery of huge number of iterations providing the novel structures.
Biomarkers includes tools and technologies that aids in dynamic and powerful approach to understand the spectrum of neurological diseases in knowing the prediction, cause, diagnosis, progression, regression, or outcome of treatment of a disease.